Attenua

PharmaceuticalsSeries ASan Mateo, USattenua.com

Latest round

Series A

Last raised

Apr 2018

Total raised

$15M

Investors

4

About Attenua

Attenua Inc.Founded in 2015 and headquartered in San Mateo, US, Attenua Inc. operates primarily in the digital domain sales sector. The company has undergone a strategic pivot towards domain acquisition and resale. In February 2020, Attenua Inc., a portfolio company of Astellas Venture Management, MPM Capital, Novartis, and Versant Ventures. The financial terms of this acquisition were not disclosed.com is positioned as a premium domain name available for purchase, which is the company's primary product offering.13 per month over 24 months. This service facilitates immediate use upon purchase, enabling clients to establish their online presence quickly. The target customers include entrepreneurs, businesses, and individuals seeking to enhance their brand identity through a memorable web address.com is based on direct sales of domain names, primarily through transactions on their website. Customers can complete purchases immediately or choose a structured payment plan, creating a steady income stream for the company. The pricing structure is straightforward, with the flagship product priced at USD 795, ensuring clarity for potential buyers.Looking ahead, Attenua Inc. The company aims to continue exploring new digital products that complement its domain sales by 2023. Additionally, it seeks to expand its market reach into new geographical regions, focusing particularly on emerging markets in Asia and Europe. Recent investment will support these initiatives, although specific details regarding new product releases or geographic targets have not yet been disclosed.

Who invested in Attenua

4 investors across 1 round

See all investors in Attenua

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Apr 17, 2018

    Amount

    $15M

    Investors

    Locked

Questions about Attenua

Who invested in Attenua?

Attenua has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Attenua raised?

Attenua has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Attenua last raise money?

Attenua's most recent round on record is a Series A, in Apr 2018.

What does Attenua do?

Attenua is a pharmaceuticals company.

Where is Attenua headquartered?

Attenua is headquartered in San Mateo, US.

Which VCs invest in companies like Attenua?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Attenua's stage. Their profiles are linked below.

Raising like Attenua? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.